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III. GENERAL INTRODUCTION 
III-1. General introduction 
 
Proteins, which have diverse functions, are essential for our life. Therefore, studies on how 
proteins are newly synthesized in cells and how proteins fold into native three -dimensional 
structures to acquire their unique functions are very important. The mammalian endoplasmic 
reticulum (ER), where the synthesis of secretory and membrane proteins take place, is equipped 
with several elaborate systems responsible for protein quality control  (1). Most of secretory 
and membrane proteins contain disulfide bonds, which are covalent bonds formed by pairs of 
cysteine residues (Fig. 1). In the ER, these proteins undergo oxidative protein folding in which 
disulfide bond formation is closely coupled to formation of three-dimensional structure  (2,3). 
Once folded properly, they are transported from the ER to their destined compartments to fulfill 
their unique functions. Misfolded proteins undergo normally either the repair of their nonnative 
structure or the degradation (4), while excess accumulation of misfolded proteins cause such 
diseases as Type II diabetes, neurodegenerative proteinopathies including Alzheimer’s, 
Huntington’s, Parkinson’s and the Creutzfeld-Jakob disease (5). Consequently, oxidative 
protein folding is important for the health of all organisms (Fig. 2).  
 
 
FIGURE 1 
Schematic representation of the formation and reduction of disulfide bond.  
 
 
Classical in vitro assays for oxidative protein folding use a small molecule, such as oxidized 
glutathione (GSSG), as an electron acceptor of reduced substrate proteins. In other words, 
GSSG contributes disulfide bonds to the substrate (6). More recently, however, it has been 
III-1. General introduction 
7 
 
shown that glutathione is not required for oxidative protein folding in the ER but rather serves 
as a reductant for disulfide isomerization or cleavage (7,8). These observations suggest  that 
other electron acceptors than glutathione catalyze disulfide bond formation in living cells. 
 
Protein disulfide isomerase (PDI) was identified as the enzyme that greatly accelerates 
oxidative protein folding reactions (9,10). PDI comprises four thioredoxin (Trx)-like domains 
named a, b, b’ and a’, forming a compact U-shape (Fig. 3) (11,12). Both PDI a and a’ domains 
commonly contain a Cys-Xaa-Xaa-Cys motif as a redox-active site essential for thiol-disulfide 
exchange reactions with substrates. PDI not only introduces disulfide bonds but also rearranges 
or reduces aberrantly formed disulfides (13). Thus, PDI has been considered to be the primary 
and efficient enzyme catalyzing oxidative protein folding in the cell.  
 
 
FIGURE 2 
Oxidative protein folding in the ER.  
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FIGURE 3 
Crystal structure of human PDI (Protein Data Bank Code 4EL1). Redox -active sites are showed by red 
spheres. 
 
 
In 1990’s, two groups independently identified ero1 as a novel gene involved in oxidative 
protein folding by the genetic and biochemical studies using the yeast Saccharomyces 
cerevisiae (7,14). They showed that yeast Ero1p, a protein encoded by the ero1 gene, is 
required for transport from the ER and oxidation of carboxypeptidase Y (CPY). In the 
beginning of the 21st century, human Ero1 was identified by Roberto Sitia’s group as a protein 
with similar functions to yeast Ero1p  (15). They revealed that human Ero1 facilitates 
disulfide bond formation in the immunoglobulin subunits through selective oxidation of PDI  
(16). Several years after, the biochemical study revealed that Ero1  indeed oxidizes PDI with 
concomitant reduction of oxygen molecule  to hydrogen peroxide on a bound flavin adenine 
dinucleotide (FAD) molecule (17,18). Moreover, crystallographic study revealed that Ero1 
forms a single globular domain highly rich in -helices and 7 intramolecular disulfides (Fig. 
4 and 5), and Ero1 oxidizes a redox-active site of PDI a’ domain selectively and preferentially  
(19-22). Ero1 contains four regulatory cysteines (Cys94, Cys99, Cys104 and Cys131) and 
another essential cysteine pair (Cys394 and Cys397) nearby the isoalloxazine ring of FAD. 
Ero1 transfers two electrons and two protons from a Cys -Xaa-Xaa-Cys motif of PDI to oxygen 
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molecule through the Cys94-Cys99 disulfide, the Cys394-Cys397 disulfide and bound FAD in 
turn. As a result, Ero1 generates hydrogen peroxide which is a reactive oxygen species (ROS). 
Since excess generation of hydrogen peroxide cause cell death due to the oxidative stress, 
Ero1 activity must somehow be regulated strictly.  
 
In living cells, Ero1 exists primarily as two redox isoforms, OX1 and OX2, that differ in the 
electrophoretic mobility on non-reducing gels (19). HPLC and MALDI-TOF MS analyses 
showed that these forms are determined by different disulfide bond formation patterns among 
the four regulatory cysteines (21); OX1 with the Cys94-Cys99 disulfide is an active form of 
Ero1 that can oxidize PDI efficiently whereas OX2 with the Cys94-Cys131 disulfide is 
completely inactive (22). Accordingly, the Ero1 Cys104Ala/Cys131Ala double mutant, 
forming the Cys94-Cys99 disulfide homogeneously, displays much higher PDI oxidation 
activity and is hence referred to as a hyperactive mutant (22,23). Thus, we already had 
some knowledge about the mechanism of Ero1 regulation when I started my doctorial research.  
 
Under the background addressed above, my PhD studies revealed that in addition to these four 
cysteines, Cys208 and Cys241 found in Ero1 family enzymes from higher eukaryotes also 
played a significant role in the regulation of Ero1 catalysis. In support of this notion, Ero1-
AASS with an additional mutation of the Cys208-Cys241 disulfide in hyperactive Ero1 
Cys104Ala/Cys131Ala double mutant , oxidized PDI with even higher efficiency and yielded 
even larger amount of H2O2 in our in vitro assays (24). In cultured cells, H2O2-responsive 
HyPer was oxidized to a greater extent by the overexpression of Ero1-AASS than by that of 
hyperactive Ero1. Doxycycline-induced expression of Ero1-AASS inhibited cell 
proliferation and decreased cell viability.  These results suggest that Ero1-induced 
hyperoxidation of the ER was detrimental to cells. Molecular dynamics (MD) simulation 
suggests the enhanced access of O2 into the FAD active site upon the cleavage of the Cys208-
Cys241 disulfide in Ero1. Accordingly, the presence of Cys208 and Cys241 is required for 
maximal catalytic turnover under reducing conditions  (25). In this context, I found that the 
redox state of the Cys208-Cys241 pair significantly influences the stability of the Cys94-
Cys131 inhibitory disulfide through allosteric and/or intermolecular communications. Thus, I 
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demonstrated that the Cys208-Cys241 pair is involved in Ero1 regulation although detailed 
mechanism are not fully understood.  
 
 
FIGURE 4 
Crystal structure of human Ero1 (Protein Data Bank Code 3AHQ). Due to the lack of electron density 
from the electron shuttle loop containing four regulatory cysteines (Cys94, Cys99, Cys104 and Cys131), 
their putative positions are illustrated by a red dotted oval . Disulfide bonds are represented by red 
sticks.  
 
 
 
 
FIGURE 5 
Disulfide bond connectivity of human Ero1.  
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IV. PROJECT 
 
Human ER oxidoreductin-1 (Ero1) undergoes dual regulation through complementary redox 
interactions with protein-disulfide isomerase 
 
 
IV-1. Abstract 
 
In the mammalian endoplasmic reticulum (ER), oxidoreductin-1 (Ero1) generates protein 
disulfide bonds and transfers them specifically to canonical protein disulfide isomerase (PDI) 
to sustain oxidative protein folding. This oxidative process is coupled to the reduction of O 2 
to H2O2 on the bound flavin adenine dinucleotide (FAD) cofactor. Since excessive thiol 
oxidation and H2O2 generation cause cell death, Ero1 activity must be properly regulated. In 
addition to the four catalytic cysteines (Cys94, Cys99, Cys104 and Cys131)  that are located in 
the flexible active site region,  the Cys208-Cys241 pair located at the base of another flexible 
loop is necessary for Ero1 regulation, although the mechanistic basis is not fully understood. 
The present study revealed that  the Cys208-Cys241 disulfide was reduced by PDI and other 
PDI family members during PDI oxidation. Differential scanning calorimetry and small -angle 
X-ray scattering showed that mutation of Cys208 and Cys241 did not grossly affect the thermal 
stability or overall shape of Ero1, suggesting that redox regulation of this cysteine pair serves 
a functional role. Moreover, the flexible loop flanked by Cys208 and Cys241 provide s a 
platform for functional interaction with PDI, which in turn enhances the oxidative activity of 
Ero1 through reduction of the Cys208-Cys241 disulfide. I propose a mechanism of dual 
Ero1 regulation by dynamic redox interactions between PDI and the two Ero1 flexible loops 
that harbor the regulatory cysteines.  
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IV-2. Introduction 
 
Many secretory and membrane proteins are synthesized in the endoplasmic reticulum (ER), in 
which proteins acquire their three-dimensional structures frequently through disulfide bond 
formation (1,2). In the mammalian ER, the network for the catalysis of protein disulfide bond 
formation (oxidative protein folding) comprises a number of oxidoreductases that include more 
than 20 protein disulfide isomerase family members (PDIs) and five or more PDI-oxidizing 
enzymes such as ER oxidoreductin-1Ero1(3-6). Most PDIs contain the Cys-Xaa-Xaa-Cys 
motif within the redox active sites of their thioredoxin (Trx)-like domains that catalyze 
disulfide introduction, isomerization or reduction in substrate proteins. Previous biochemical 
studies indicated that ERp46 and P5, in concert with the preferred partner peroxiredoxin 4 
(Prx4) (7,8), are dedicated to the rapid but promiscuous introduction of disulfides during the 
early stages of oxidative protein folding (5). Conversely, PDI, in combination with Ero1, is 
involved in the later folding steps that involve selective formation of native disulfide bonds 
and/or the proofreading of non-native disulfide bonds (5). Other PDI-oxidizing enzymes such 
as glutathione peroxidases 7 or 8 (GPx7/GPx8)  (9) and vitamin K epoxide reductase (VKOR) 
are also reported to potentially contribute to  oxidative protein folding (10). 
 
Ero1 family members are highly conserved in eukaryotes, and two isoforms, Ero1 and Ero1 , 
are found in vertebrates . Ero1 is expressed ubiquitously (11) whereas Ero1  is mostly 
expressed in the pancreas and stomach (12,13). Although yeast Ero1p is essential for cell 
viability (14), Ero1/ double-knockout mice do not display a significant phenotype, and 
oxidative folding of immunoglobulin proceeds normally in double-knockout cells (15). These 
results indicate the presence of backup systems that can complement and compensate for Ero1 
in mammals. 
 
When Ero1 oxidizes PDI, flavin adenine dinucleotide (FAD) bound to Ero1 accepts 
electrons from PDI and subsequently reduces O 2 to H2O2 (4), which is further reduced to H2O 
by Ero1-associated GPx7/GPx8 (9,16,17). However, excessive formation of disulfide bonds 
and H2O2 can cause cell death (18), and hence it is essential that Ero1 activity is strictly 
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regulated. The disulfide bond pattern among four regulatory cysteines (Cys94, Cys99, Cys104 
and Cys131) in the so-called electron shuttle loop (residues Asp90Cys131) is a primary 
determinant of Ero1 activity; the catalytic Cys94-Cys99 active site disulfide is present in the 
active form, whereas Cys94-Cys131 and Cys99-Cys104 disulfides are present in the inactive 
form (19-22). More recently, I demonstrated that in addition to these four regulatory cysteines, 
the Cys208-Cys241 pair that is conserved in vertebral Ero1 family enzymes has an auxiliary 
role in the regulation of Ero1. The Ero1 Cys104Ala/Cys131Ala/Cys208Ser/Cys241Ser 
quadruple mutant displays higher PDI oxidation activity and H2O2 production, and is therefore 
more toxic than the Ero1 Cys104Ala/Cys131Ala double mutant (18). Furthermore, under high 
turnover conditions in which reduced PDI is constantly regenerated by reducing reagents such 
as reduced glutathione (GSH), the presence of Cys208 and Cys241 was required for maximal 
PDI oxidation activity (23). Additionally, formation of the Ero1-PDI complex involves 
Cys208 and/or Cys241 of Ero1 in human cells (18), and the Cys208-Cys241 pair interacts 
with PDI to fine-tune Ero1 activity. 
 
Importantly, all of the aforementioned regulatory cysteines are located in flexible loop regions 
of Ero1. It is assumed that the redox state of these cysteines influences the conformational 
dynamics of the flexible loops, thereby altering Ero1 activity. Consistent with this, the 
electron shuttle loop (loop I) that includes the Cys94-Cys99 disulfide in the active form is 
more flexible and has a higher affinity for PDI than the loop containing Cys94 -Cys131 and 
Cys99-Cys104 disulfides in the inactive form, which facilitates electron transfer from PDI to 
the bound FAD cofactor (21). In the present study, I focused on the role of another flexible 
loop flanked by Cys208 and Cys241 (loop II) in the regulation of Ero1 activity (Fig. 1A). The 
results showed that the Cys208-Cys241 disulfide was significantly reduced during Ero1-
catalyzed oxidation of PDI, resulting in a more active Ero1. Deletion of loop II prevented the 
reduction of the Cys208-Cys241 disulfide by PDI, but the overall structure of Ero1 was not 
altered. Loop II therefore serves as a platform for functional interplay with PDI, which in turn 
elevates Ero1 activity through the reduction of the Cys208-Cys241 disulfide. The present 
findings shed new light on the mechanisms of PDI-mediated Ero1 regulation in the 
mammalian ER. 
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FIGURE 1. A 
Ribbon diagram of the crystal structure of Ero1-AA (Protein Data Bank code 3AHQ). The putatively 
modeled loop I (the electron shuttle loop) including Cys94, Cys99, Cys104 and Cys131, and the 
putatively modeled loop II containing Cys208 and Cys241 are drawn as black and red broken lines, 
respectively. 
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IV-3. Results 
 
1. Reduction of the Cys208-Cys241 disulfide during Ero1-catalyzed PDI oxidation 
 
My previous observation that the Ero1 Cys104Ala/Cys131Ala/Cys208Ser/Cys241Ser 
quadruple mutant oxidizes PDI more efficiently and produces more H2O2 than the Ero1 
Cys104Ala/Cys131Ala double mutant suggests that the Cys208-Cys241 disulfide has a role in 
regulating Ero1 (18,23). To investigate the reduction of the Cys208-Cys241 disulfide by PDI 
during Ero1 catalysis, which leads to further elevation of Ero1 activity, I first sought to 
measure the change in redox state of Ero1 during PDI oxidation. However, because of 
significant overlap of these two similar-sized proteins in SDS-PAGE, it was difficult to monitor 
PDI-induced redox state changes of Ero1 using the method (data not shown). I therefore fused 
maltose binding protein (MBP) to the N-terminus of PDI and reacted the resulting fusion 
protein (MBP-PDI) with Ero1 
 
Ero1 in combination with MBP-PDI consumed molecular oxygen at almost the same rate as 
when in combination with PDI (Fig. 1B). 
 
 
FIGURE 1. B 
O2 consumption coupled to PDI or MBP-PDI oxidation catalyzed by Ero1-AA. All experiments were 
performed by mixing Ero1-AA (4 M) with reduced PDI or MBP-PDI (10 M) in air-saturated buffer 
containing GSH (10 mM) at 30°C.
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As previously observed with PDI (18), MBP-PDI was oxidized more efficiently by Ero1-
AASS (Cys104Ala/Cys131Ala and Cys208Ser/Cys241Ser quadruple mutant) than by Ero1-
AA (Cys104Ala/Cys131Ala double mutant) (Fig. 1C and 1D, upper left and right). Thus, the 
fusion of MBP had minimal effect on the reaction between PDI and Ero1. A weak but 
significant band (marked by “red”) did appear in the upper part of the Ero1-AA band (marked 
by “oxi”) during the early stages (0.25 to 1.5 min) of MBP-PDI oxidation by Ero1-AA and 
disappeared as the reaction proceeded to completion (Fig. 1D, upper left). This “red” band was 
not observed with Ero1-AASS in which Cys208 and Cys241 were mutated to Ser (Fig. 1D, 
upper right). These results suggested that a portion of Ero1 underwent reduction of the 
Cys208-Cys241 disulfide by reaction with reduced PDI. Ero1-Cysless 
(Cys94Ala/Cys99Ala/Cys104Ala/Cys131Ala quadruple mutant), which is incapable of 
oxidizing PDI via its active site, generated an even larger amount of the “red” species 
throughout the entire reaction (0.25 to 10 min; Fig. 1C and 1D, middle left). As expected, the 
“red” band was hardly detectable for Ero1-CyslessSS 
(Cys94Ala/Cys99Ala/Cys104Ala/Cys131Ala and Cys208Ser/Cys241Ser sextuple mutant; 
middle right), as was the case for Ero1-AASS. The slight appearance of this band with the 
Ero1-CyslessSS mutant during the later stages of the reaction may indicate only partial 
reduction of the two solvent-exposed disulfide bonds in the N-terminal region (Cys35-Cys48 
and Cys37-Cys46). It is conceivable that the Cys208-Cys241 disulfide in Ero1 could be 
reduced to a significant extent by PDI during catalysis provided that sufficient amounts of 
reduced PDI are present. 
 
The “red” species was also abundant with Ero1-WT (Fig. 1C and 1D, lower left), and despite 
the Cys208Ser/Cys241Ser double mutations, this was also the case with Ero1-WTSS, albeit 
to a lesser extent than with Ero1-WT (Fig. 1D, lower right). This observation suggests that a 
disulfide bond, possibly in the loop I of Ero1 can also be reduced (to some extent) by PDI.  
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FIGURE 1. C 
Ero1 mutants used in this study.   
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FIGURE 1. D 
Time course of the redox-state changes of MBP-PDI and Ero1 mutants during the Ero1-catalyzed 
MBP-PDI oxidation. All experiments were initiated by mixing each Ero1 mutant (4 M) with reduced 
MBP-PDI (10 M) in air-saturated buffer at 30°C. At indicated time points, the reaction mixture was 
quenched with TCA, washed with acetone, and mod ified by maleimide-PEG-2k or AMS (Fig. 1E). The 
redox states of MBP-PDI and Ero1 mutants were separated by non-reducing SDS-PAGE and stained 
with CBB. Note that the “red” species of Ero1-WT are observed at 0 min because Ero1-WT includes 
OX1 and OX2 forms that differ in their electrophoretic mobility on non -reducing gels without 
modification, as reported previously (19,21,41). 
  
IV-3. Project-Results 
22 
 
 
 
FIGURE 1. E 
Chemical structures of alkylating agents for thiol of cysteine: maleimide-PEG-2k and 4-acetamide-
4’-maleimidylstilbene-2,2’-disulfonic acid (AMS).  
  
Maleimide-PEG-2k 
AMS 
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To confirm that the “red” band  actually corresponded to a species with a reduced Cys208 and 
Cys241, I carried out peptide foot-printing analysis. Gel fragments corresponding to the “red” 
and “oxi” bands of Ero1-Cysless were individually subjected to in-gel digestion, and the 
resulting short peptides were separated by HPLC and analyzed by MALDI-TOF MS (Fig. 1F 
and 1G). The peptide fragments identified are listed in Table 1. The elution peak marked by 
“#” had a molecular mass equivalent to that of Ero1 residues Gly193Lys215 containing an 
AMS-modified Cys208 (Fig. 1F, upper and 1G, upper). For further confirmatory evidence, I 
synthesized this peptide, treated it with AMS and performed HPLC/MALDI-TOF MS analysis 
(Fig. 1H). The synthetic peptide was eluted at the same elution time as the peak marked “#” 
and had an identical molecular mass. The corresponding elution peak was significantly weaker 
in the elution profile of digested peptides derived from the “oxi” band, and was not contained 
peptide of Ero1 residues Gly193Lys215 containing an AMS-modified Cys208 (Fig. 1F, 
lower and 1G, lower). An Ero1 species with reduced Cys208 and Cys241 was therefore 
generated during Ero1-catalyzed PDI oxidation. 
 
 
 
FIGURE 1. F 
HPLC profiles of digested fragments from the “red” (upper) and “oxi” (lower) species of Ero1-
Cysless. The elution fractions marked by # and ǂ were analyzed by MALDI-TOF MS as shown in (G). 
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FIGURE 1. G 
MALDI-TOF MS spectra of fractions marked # and ǂ in (F). 
 
 
 
FIGURE 1. H 
HPLC profile (upper) and MALDI-TOF MS (lower) of a synthesized peptide composed of the Ero1 
Gly193Lys215 segment including AMS-modified Cys208. The fraction marked * was analyzed by 
MALDI-TOF MS. 
IV-3. Project-Results 
25 
 
TABLE 1 
Mapping of digested Ero1 peptides 
  
Sample subjected 
to in-gel digestion 
HPLC 
retention time 
(min) 
AMS Peptides 
Cysteine 
contained in 
the peptide 
Modification 
Calculated 
mass 
Observed 
mass 
Ero1 (red) 
30.6 + 193GPDAWKIWNVIYEENCFKPQTIK215 Cys208 AMS 3271.9 3272.0 
        
Ero1
 red and oxi) 
5.2 + 250LISGLHASINVHLSAR265   1688.0 1688.1 
8.6 + 438QEIVSLFNAFGR449   1380.7 1381.1 
 9.9 + 98DAAVKPAQSDEVPDGIK114   1739.9 1740.0 
 10.3 + 414ILFSEKLIANMPESGPSYEFHLTR437   2801.4 2801.7 
 11.2 + 19GSHMGEEQPPETAAQR34   1724.8 1725.1 
 12.4 + 61LFPRLQKLLESDYFR75   1947.1 1947.2 
 13.1 + 370EAHKLKEDFR379   1272.7 1272.9 
 13.3 + 188YTGYKGPDAWK198   1285.6 1285.8 
 14.7 + 276KWGHNITEFQQR287   1543.8 1544.2 
 14.7 + 97RDAAVKPAQSDEVPDGIK114   1896.0 1896.4 
 15.2 + 277WGHNITEFQQR287   1415.7 1416.0 
 15.2 + 399LWGKLQTQGLGTALK413   1613.9 1614.1 
 15.4 + 342MLLLEILHEIK352   1351.8 1351.9 
 15.4 + 303NLYFLYLIELRALSK317   1878.1 1878.3 
 15.9 + 266YLLQETWLEKK276   1450.8 1450.1 
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 15.9 + 303NLYFLYLIELR313   1456.8 1457.0 
 16.3 + 137LGAVDESLSEETQK150   1505.7 1506.0 
 17.8 + 403LQTQGLGTALK413   1129.7 1129.9 
 19.7 + 376EDFRLHFR383   1119.6 1119.9 
 19.7 + 353SFPLHFDENSFFAGDK368   1857.8 1858.3 
 19.8 + 68LLESDYFR75   1042.5 1042.9 
 20.1 + 288FDGILTEGEGPR299   1290.6 1291.0 
 20.5 + 450ISTSVKELENFR461   1422.8 1423.2 
 21.5 + 318VLPFFERPDFQLFTGNKIQDEENK341   2933.5 2933.3 
 22.1 + 438QEIVSLFNAFGRISTSVK455   1996.1 1996.6 
 22.9 + 420LIANMPESGPSYEFHLTR437   2062.0 2062.7 
 22.9 + 245RAFYRLISGLHASINVHLSAR265   2381.3 2381.8 
 24.7 + 35CFCQVSGYLDDCTCDVETIDRFNNYR60 
Cys35 
Cys37 
Cys46 
Cys48 
35S-S48 
disulfide 
 
37S-S46 
disulfide 
3075.3 3076.4 
 25.2 + 353SFPLHFDENSFFAGDKK369   1985.9 1986.6 
 25.7 + 266YLLQETWLEK275   1322.7 1323.2 
 25.7 + 374LKEDFRLHFR383   1360.7 1361.2 
 29.5 + 246AFYRLISGLHASINVHLSAR265   2225.2 2224.8 
 29.8 + 158HDDSSDNFAEADDIQSPEAEYVDLLLNPER187   3404.5 3405.4 
 30.6 + 318VLPFFERPDFQLFTGNK334   2055.1 2055.7 
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2. Efficient reduction of the Ero1 Cys208-Cys241 disulfide by PDI and ERp46  
 
I next explored whether the Cys208-Cys241 disulfide in Ero1 could be reduced selectively 
by PDI or non-selectively by PDI family members. To this end, I assessed how efficiently 
Ero1-Cysless was converted into the “red” species upon reaction with separate PDI family 
enzymes. While Ero1-Cysless could be reduced to some extent by all tested PDIs, PDI and 
ERp46 were the particularly efficient producers of the “red” species of Ero1 within 0.25 min 
(Fig. 2A). Meanwhile, Ero1-CyslessSS did not exhibit this upward band shift upon addition 
of any PDI family enzyme, as expected due to the lack of Cys208 and Cys241 . ERp57, which 
has a similar overall domain arrangement to PDI, catalyzed a slower reduction of the Cys208-
Cys241 disulfide than did PDI. After a 10 min incubation, however, ERp57 generated an 
equivalent amount of the “red” Ero1 species as did PDI (Fig. 2B). Statistical analysis of the 
time course of the change in redox state of Ero1 indicated that PDI and ERp46 produced the 
“red” Ero1 species at a faster rate than did the other tested PDIs (Fig. 2C). 
 
I next explored whether the Ero1 Cys208-Cys241 pair has a preference for thiol -disulfide 
exchange with the PDI a’ domain active site or the a domain active site. For this purpose, 
Ero1-Cysless was incubated with two different PDI mutants in which the redox active site 
cysteines in either the a or a’ domain were replaced by alanines. The resulting constructs were 
named PDI AXXA-CXXC and PDI CXXC-AXXA, respectively. PDI AXXA-CXXC reduced 
Ero1-Cysless more efficiently than PDI CXXC-AXXA (Fig. 2D), indicating that the C-
terminal a’ domain serves as a more efficient reductant of the Ero1 Cys208-Cys241 disulfide 
than the N-terminal a domain. The time course of the change in the Ero1 redox state 
confirmed the higher reactivity of PDI AXXA-CXXC with the Ero1 Cys208-Cys241 disulfide 
compared with PDI CXXC-AXXA (Fig. 2E and 2F). These results were consistent with our 
previous observation of mixed-disulfide complexes trapped in the ER of living cells  (18). 
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FIGURE 2. A 
Redox states of Eo1 mutants during Ero1-catalyzed PDI oxidation. All experiments were initiated 
by mixing Ero1-Cysless or Ero1-CyslessSS (4 M each) with reduced PDIs (10 M each) in air-
saturated buffer at 30°C. At 0.25 min into the reaction, the mixture was quenched with TCA, washed 
with acetone, and modified by AMS. The redox states of Ero1 mutants were assessed by non-reducing 
SDS-PAGE, followed by immunoblotting with Ero1 antibody (upper). The lower panel indicates the 
quantification and statistical analysis of the “red” fraction of Ero 1-Cysless shown in the upper panel 
(n = 3, mean ± SD). Note that Ero1-CyslessSS migrates more slowly on a non-reducing gel than does 
Ero1-Cysless, due to the absence of the Cys208-Cys241 long-range disulfide. n.s., not significant; *p  
<0.05; **p <0.01. 
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FIGURE 2. B 
Time course of the redox state changes of Ero1 mutants during incubation of Ero1-Cysless or Ero1-
CyslessSS (4 M each) with reduced PDIs (10 M each). All experiments were performed as described 
in Fig. 1D. The redox states of Ero1 mutants were detected as described in (A). 
 
 
 
FIGURE 2. C 
Quantification and statistical analysis of the “red” fraction of Ero1-Cysless shown in (B) (n = 3, mean 
± SD).  
IV-3. Project-Results 
30 
 
 
 
FIGURE 2. D 
Redox states of Ero1-Cysless during reaction with the reduced form of PDI mutants in which a CXXC 
sequence in either the a or a’ domain is replaced with AXXA. All experiments were performed as 
described in (A) (left). The right panel indicates the quantification of “red” Ero1-Cysless species 
shown in the left panel (n = 3, mean ± SD). **p <0.01; ***p <0.001. 
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FIGURE 2. E 
Time course of the redox state changes of Eo1-Cysless during incubation with the reduced form of 
PDI active-site mutants. All experiments were performed as described in Fig. 1D. 
 
 
 
 
FIGURE 2. F 
Quantification and statistical analysis of the “red” fraction of Ero1-Cysless shown in (E) (n = 3, mean 
± SD). 
  
IV-3. Project-Results 
32 
 
3. Role of the Cys208-Cys241 disulfide in the overall structure of Ero1 
 
In general, there are three functions of protein disulfide bonds; structural disulfides that 
stabilize the conformation of proteins (24-27), catalytic disulfides that directly engage in redox 
reactions, and regulatory disulfides that modulate enzymatic activities (3,4). To investigate the 
effect of the Cys208-Cys241 disulfide on the conformational stability of Ero1, I performed 
differential scanning calorimetry (DSC) measurements for Ero1-AA, Ero1-AASS, Ero1-
WT and Ero1-WTSS at scan rates of 60, 120 and 200°C/h (Fig. 3A). Although Ero1 appears 
to assume a single-domain globular fold, all constructs displayed two or more melting points 
during heat denaturation, indicating a non-2-state denaturation process for Ero1. 
Thermodynamic parameters of this denaturation were calculated by fitting a non-2-state model 
using ORIGIN software (Origin Lab) (Fig. 3B and Table 2). The denaturation of Ero1 
involved two melting temperatures, Tm1 and Tm2, a three-state model that included native, 
partially denatured and fully denatured states was the best fit. Ero1-AASS showed a 3.8°C 
higher Tm1 value than Ero1-AA (Table 2), and a significant increase in Tm1 was observed 
with the double mutant Cys208Ser/Cys241Ser in the presence of Ero1-WT-based constructs 
(i.e., Ero1-WTSS vs Ero1-WT). Additionally, Ero1-WT-based constructs tended to have 
higher Tm1 values than Ero1-AA-based constructs, indicating that the presence or absence of 
disulfide bonds in loop I and loop II influences the first thermal denaturation step of Ero1 
By contrast, Tm2 was affected to a much lesser extent by disulfide bonds in loops I and II 
(Table 2), suggesting that the second denaturation step could be ascribed primarily to the 
denaturation of the main -helical domain of Ero1. In general, the Tm2 value was comparable 
among all Ero1 mutants tested, regardless of the scan rate (Fig. 3A and Table 2), indicating 
that Ero1 retained virtually all thermodynamic stability upon deletion of the Cys208-Cys241 
disulfide. 
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FIGURE 3. A 
DSC curves of Ero1-AA, Ero1-AASS, Ero1-WT and Ero1-WTSS. DSC measurements were 
performed at scan rates of 60, 120, 200°C/h.  
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FIGURE 3. B 
Non-2-state fit of DSC curves for Ero1-AA, Ero1-AASS, Ero1-WT, and Ero1-WTSS in (A). 
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TABLE 2 
DSC thermodynamic parameters  
 
 
  
Scan rate 60°C/h 120°C/h 200°C/h 
 
Tm1 
ΔH1 
(Tm1) 
Tm2 
ΔH2 
(Tm2) 
 Tm1 
ΔH1 
(Tm1) 
Tm2 
ΔH2 
(Tm2) 
 Tm1 
ΔH1 
(Tm1) 
Tm2 
ΔH2 
(Tm2) 
 °C kJ/mol °C kJ/mol  °C kJ/mol °C kJ/mol  °C kJ/mol °C kJ/mol 
Ero1-AA 
46.9 
± 0.1 
217 
± 7 
58.7 
± 0.1 
132 
± 2 
 
46.7 
± 0.3 
157 
± 19 
60.0 
± 0.1 
141 
± 9 
 
46.2 
± 0.6 
159 
± 15 
61.3 
± 0 
162 
± 6 
Ero1-AASS 
50.7 
± 0.3 
248 
± 30 
57.4 
± 0 
133 
± 8 
 
51.3 
± 0.1 
203 
± 28 
58.7 
± 0.1 
149 
± 3 
 
49.6 
± 0.6 
190 
± 57 
60.4 
± 0 
143 
± 9 
Ero1-WT 
51.3 
± 0.2 
230 
± 20 
58.8 
± 0 
129 
± 3 
 
51.5 
± 0.1 
232 
± 20 
60.0 
± 0 
134 
± 2 
 
52.3 
± 0.2 
202 
± 5 
61.1 
± 0 
131 
± 1 
Ero1-WTSS 
53.8 
± 0 
166 
± 1 
58.4 
± 0.1 
158 
± 2 
 
54.2 
± 0.1 
203 
± 4 
59.4 
± 0 
151 
± 1 
 
54.7 
± 0.1 
244 
± 9 
60.4 
± 0 
142 
± 1 
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To gain further insight into the role of the Cys208-Cys241 disulfide in the overall fold of Ero1, 
I carried out small-angle X-ray scattering (SAXS) measurements. Fig. 4A shows the SAXS 
profiles of Ero1-AA and Ero1-AASS extrapolated to zero concentration. Guinier plots are 
linear without any upward curvature at low Q2 (Fig. 4A, inset), indicative of no protein 
aggregation. The apparent radius of gyration, Rg, and the normalized forward intensity, I(0)/c, 
were determined from the slope and intercept of the linear fits (Fig. 4B and Table 3). The Rg 
values of Ero1-AA and Ero1-AASS were estimated to be 26.6 ± 0.1 and 26.2 ± 0.1 Å, 
respectively. The molecular mass estimated from the normalized forward intensity I(0) value 
using bovine serum albumin (BSA; 66.4 kDa) as the standard reference was 54.3 kDa for both 
Ero1-AA and Ero1-AASS, suggesting both were monomeric in solution. Furthermore, the 
pair distribution function, P(r), was calculated from the SAXS curves using GNOM (28), and 
P(r) for Ero1-AASS was almost superimposable to that of Ero1-AA (Fig. 4C), although the 
largest r value (Dmax) of Ero1-AA and Ero1-AASS was 96 and 92 Å, respectively (Table 3). 
These results suggest that the overall molecular shape of Ero1 was not altered by the 
Cys208Ser/Cys241Ser double mutation. 
 
 
FIGURE 4. A 
SAXS profiles of Ero1-AA (blue) and Ero1-AASS (red). The inset shows Guinier plots of Ero1-
AA and Ero1-AASS from Guinier analysis using the Q range (highlighted data points in the inset) 
shown in Table 3.  
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FIGURE 4. B 
The protein concentration dependence of the normalized forward intensities ( I(0)/c, upper) and the 
apparent radius of gyration (Rg, lower) of Ero1-AA and Ero1-AASS are shown.  
 
 
 
FIGURE 4. C 
Pair distribution function P(r) of Ero1-AA (blue) and Ero1-AASS (red). 
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TABLE 3 
SAXS structural parameters 
 
 
  
 
Rga Rgb I(0)a I(0)b Dmaxc Vpd MMe MMf MMg 
Oligomeric 
State 
 (Å) (Å) (a.u.) (a.u.) (Å) (Å3) (kDa) (kDa) (kDa) - 
Ero1-AAh 26.6 ± 0.1 26.54 ± 0.05 17.75 ± 0.03 17.68 ± 0.02 96 9.99 x 104 55.2 60.5 54.3 Monomer 
Ero1-AASSh 26.2 ± 0.1 26.19 ± 0.05 17.49 ± 0.03 17.46 ± 0.02 92 1.02 x 105 54.4 61.8 54.3 Monomer 
BSAi 27.7 n.d. 21.35 ± 0.01 n.d. n.d. n.d. n.d. n.d. 66.4 Monomer 
aGuinier analysis using the Q range from 0.01562 to Qmax <1.3/Rg. bEstimates in real space upon P(r) determination. cMaximum 
dimension estimated using the GNOM package. dPorod Volume. eMolecular mass calculated using the I(0) value for BSA as the 
standard. fMolecular mass calculated according to the empirical relationship MM = VP/1.65 (42). gTheoretical molecular mass 
calculated according to amino acid sequences. hExtrapolated to infinite dilution. iAt a concentration of 2.75 mg/mL (39). 
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In previous crystallographic study on human Ero1, the electron density was completely 
missing for both loop I and loop II (see Fig. 1A), indicating considerable flexibility in these 
two segments (21). To further analyze the conformation of Ero1 in these flexible regions, the 
ensemble optimization method (EOM) was performed using the SAXS data (29) and the Ero1 
crystal structure (PDB 3AHQ) as a rigid body scaffold. Consequently, whereas a SAXS curve 
estimated from any certain conformation of Ero1 did not coincide with the observed curve, 
ensembles of multiple conformations with distinct loop I and loop II struct ures produced a 
better fit (Fig. 4D). However, it was impossible to reach an optimal ensemble of different Rg 
and Dmax values for both Ero1-AA and Ero1-AASS, because the conformational distribution 
did not converge into a unique pattern (Fig. 4E). Such diversity in allowed conformation 
ensembles suggests that Ero1 in solution is likely to be highly dynamic, particularly in the 
loop I and loop II regions. 
 
Together, the thermodynamic and structural analyses indicated that the overall fold of Ero1 
was not altered by mutation of the Cys208-Cys241 pair. In other words, the Cys208-Cys241 
disulfide functions mainly as a regulatory disulfide that fine-tunes the activity of Ero1. 
However, the influence of its structural role that determines the thermodynamic stability of 
Ero1 cannot be ignored (see the next section) . 
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FIGURE 4. D 
Curves drawn with black dots correspond to the experimental SAXS curves of Ero1-AA (upper) and 
Ero1-AASS (lower). Each experimental SAXS curve is offset for clarity of presentation. Values in 
parentheses represent 2 values resulting from fitting of the theoretical SAXS curve ( red) to the 
experimental data (black dots). The data are best explained using the  ensemble optimization method 
(EOM).  
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FIGURE 4. E 
Distribution of Rg and the largest r value, Dmax, for Ero1-AA (upper) and Ero1-AASS (lower) 
predicted by EOM analysis. Representative models of members of the conformational ensemble are 
shown. The modeled structures are composed of the Ero1 crystal structure with a rigid body (cyan) 
and putative flexible loops that are missing in the crystal structure.  
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4. Deletion of loop II mimics the phenotypes of Ero1-AASS 
 
The fact that loop II is not conserved in yeast Ero1p suggests that Ero1 family enzymes in 
higher eukaryotes acquired a new mechanism of regulation through the insertion of this loop 
region. To explore the enzymatic role of this loop, I constructed Ero1 mutants Ero1-AA 
and Ero1-AASS, in which the Arg216Gly239 segment corresponding to loop II was 
deleted in Ero1-AA and Ero1-AASS, respectively (Fig. 5A).  
 
 
 
FIGURE 5. A 
Construction of Ero1-mutants: Ero1-AA, Ero1-AASS and Ero1-Cysless 
 
 
I first monitored the time course of PDI oxidation by these Ero1 mutants in the absence of 
GSH (Fig. 5B, upper). Ero1-AASS oxidized PDI with higher efficiency than did Ero1-AA 
(Fig. 5C). Noticeably, both Ero1-AA and Ero1-AASS oxidized PDI faster than Ero1-
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AA, indicating that deletion of loop II enhanced the PDI oxidation activity of Ero1. Thus, 
these mutants likely adopt a conformation similar to that of the hyperactive Ero1-AASS (18) 
(see the Discussion below). 
 
As previously reported (23), the presence of GSH dramatically changes the ranking of the 
oxidative activity of Ero1 mutants; under conditions where reduced PDI is constantly 
regenerated by GSH, NADPH consumption driven by Ero1-AASS was not faster, but rather 
slower than that by Ero1-AA (Fig. 5B, lower and 5D). Again, both Ero1-AA and Ero1-
AASS displayed similar kinetics to Ero1-AASS; mutants lacking loop II oxidized PDI more 
slowly than Ero1-AA in the presence of GSH. 
 
 
 
FIGURE 5. B 
Schematic representation of the Ero1-catalyzed PDI oxidation assay system in the absence (upper) 
and presence of GSH, GR and NADPH ( lower).  
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FIGURE 5. C 
Time course of the changes in redox state of PDI during Ero1 mutant-catalyzed PDI oxidation. All 
experiments were initiated by mixing each Ero1 mutant (4 M) with reduced PDI (100 M) in air-
saturated buffer at 30°C. At the indicated time points, the reaction was quenched with sample buffer 
containing maleimide-PEG-2k. The redox states of PDI were separated by non-reducing SDS-PAGE 
and stained with CBB (upper). Fractions of reduced (red) PDI, partially oxidized (PO) PDI and oxidized 
(oxi) PDI in the upper panel were quantified using an LAS-3000 image reader and plotted as a function 
of reaction time (n = 3, mean ± SD) (lower). 
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FIGURE 5. D 
NADPH consumption coupled to PDI oxidation catalyzed by each Ero1 mutant. All experiments were 
performed in air-saturated buffer containing NADPH (200 M), GR (1 U), GSH (1 mM), reduced PDI 
(10 M) and each Ero1 mutant (4 M) at 30°C. 
 
 
I also measured O2 consumption and H2O2 production in the absence and presence of GSH. 
These assays also demonstrated that although the Ero1 mutants lacking loop II oxidized PDI 
faster and hence generated higher levels of H2O2 than Ero1-AA in the absence of GSH (Fig. 
5E, left and 5F, left), the opposite was true in the presence of GSH; Ero1-AA consumed O2 
fastest and hence produced the largest amount of H 2O2 among the Ero1 derivatives tested. 
(Fig. 5E, right and 5F, right). 
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FIGURE 5. E 
O2 consumption coupled to PDI oxidation catalyzed by Ero1 mutants. All experiments were initiated 
by mixing each Ero1 mutant (4 M) with reduced PDI (100 M) (left) or by mixing each Ero1 
mutant (4 M) with reduced PDI (10 M) in the presence of GSH (1 mM), GR (1 U) and NADPH (200 
M) (right) in air-saturated buffer at 30°C, as shown in Fig. 5B. 
 
FIGURE 5. F 
H2O2 generation during PDI oxidation catalyzed by Ero1 mutants. All experiments were initiated by 
mixing each Ero1 mutant (4 M) with reduced PDI (100 M) (left) or by mixing each Ero1 mutant 
(4 M) with reduced PDI (10 M) in the presence of GSH (1 mM), GR (1 U) and NADPH (200 M) 
(right) in air-saturated buffer at 30°C, as shown in Fig. 5B (n = 3, mean ± SD). Note that the H2O2 
concentration decreases during the later stages of the reaction due to PDI -mediated scavenging of H2O2 
as reported previously (18). 
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To address the mechanistic influence of loop II on Ero1 activity in the presence of GSH, I 
analyzed the redox state of Ero1 loop II deletion mutants during catalytic PDI oxidation. As 
expected, a significant portion of Ero1-AA was reduced by PDI in the presence of GSH (Fig. 
6A, left), but this reduction was significantly delayed with Ero1-AA (Fig. 6A, right). Thus, 
deletion of loop II inhibited PDI-mediated reduction of the Cys208-Cys241 disulfide. Given 
that the redox interaction between PDI and the Cys208-Cys241 pair is rate-limiting under such 
reductive conditions (23), this finding likely explains the compromised  catalytic activity of 
Ero1-AA in the presence of GSH (Fig. 5C-E; see also the Discussion below). Furthermore, 
in the absence of GSH, Ero1-AA was reduced by PDI to a much lesser extent compared with 
Ero1-AA (Fig. 6B, left), as was Ero1-Cysless compared to Ero1-Cysless (see Fig. 2B and 
6B, right). These results suggest that loop II plays a significant role in the efficient reduction 
of the Ero1 Cys208-Cys241 disulfide by PDI. However, in the absence of GSH, loop II 
deletion mutants appear to adopt an active, Ero1-AASS-like conformation that is independent 
of the redox state of the Cys208-Cys241 pair (see the Discussion below). 
 
 
 
FIGURE 6. A 
Time course of the change in redox state of Ero1 mutants during incubation with reduced MBP-PDI. 
All experiments were performed in air-saturated buffer containing NADPH (200 M), GR (1 U), GSH 
(1 mM), reduced PDI (10 M) and each Ero1 mutant (4 M) at 30°C, as described in Fig. 1D. 
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FIGURE 6. B 
Redox state changes of Ero1 loop II deletion mutants during incubation with reduced MBP-PDI. All 
experiments were performed in air-saturated buffer at 30°C by mixing each Ero1 mutant (4 M) with 
reduced MBP-PDI (10 M). At 0.25 min into the reaction (upper) or at other indicated time points 
(lower), the reaction mixture was quenched with TCA, washed with acetone, and modified by AMS. 
The redox states of Ero1 mutants were assessed as described in Fig. 1D. 
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IV-4. Discussion 
 
My previous study demonstrated that the human Ero1 
Cys104Ala/Cys131Ala/Cys208Ser/Cys241Ser quadruple mutant oxidizes PDI more rapidly 
and therefore produces more H2O2 than does Ero1 Cys104Ala/Cys131Ala with the Cys208-
Cys241 disulfide intact. As a result, cell proliferation is greatly inhibited and cell viability 
significantly diminished (18), indicating a physiologically significant role in regulation for  
Ero1 Cys208 and Cys241. Consistent with this, the Cys208-Cys241 pair is highly conserved 
in Ero1 family enzymes in higher eukaryotes, although not in the yeast enzyme Ero1p (4). 
 
The present study revealed that mutation of Cys208 and Cys241 had little effect on the 
thermodynamic stability and overall shape of Ero1 (Fig. 3, 4B, Table 2 and 3), leading to 
conclude that the Cys208-Cys241 disulfide functions mainly as a regulatory element that fine-
tunes the Ero1 activity. The Cys208-Cys241 disulfide was preferentially reduced by two 
members of the PDI family; PDI and ERp46 (Fig. 2A-C). In this context, previous studies 
indicated that Ero1 is capable of selectively oxidizing PDI and, to a lesser extent, ERp46 (5), 
while Ero1 is incapable of efficiently oxidizing other members of the PDI family (30). The 
present study also showed that the Cys208-Cys241 disulfide was reduced by the PDI a’ domain 
more efficiently than by the a domain (Fig. 2D-F). In line with this, Ero1 preferentially 
oxidizes the PDI a’ domain, and oxidizes the a domain to a lesser extent (30,31). Thus, there 
seems to be a close correlat ion between the reactivity of PDIs with the Ero1 Cys208-Cys241 
disulfide and the selective oxidation of PDIs by the Ero1 active site Cys94-Cys99. 
 
In this study, I demonstrated that reduction of the Cys208-Cys241 disulfide increased the 
oxidative activity of Ero1 (Fig. 5, 6A and 6B). As shown in Fig. 7, the proportion of Ero1 
with a reduced Cys208-Cys241 pair increased with absolute levels of reduced PDI (Fig. 7B and 
7D). I also observed that the Cys208-Cys241 disulfide could be reduced more effectively by a 
combination of PDI and GSH than by GSH alone (Fig. 7A and 7B). Together, these results show 
the differences in the reactivity of Ero1 in the presence and absence of GSH are dependent 
on the availability of reduced PDI or the rate of recycling of reduced PDI. In this respect, GSH 
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may serve as an indirect enhancer of Ero1 activity. 
 
 
 
FIGURE 7. A 
Reduction of the Cys208-Cys241 disulfide of Ero1-AA (left) and Ero1-Cysless (right) in the 
presence of different concentrations of GSH. All experiments were initiated by mixing Ero1-AA or 
Ero1-Cysless (4 M) with GSH (0-5 mM) in buffer at 30°C. At 0.25 min into the reaction, the mixture 
was quenched with TCA, washed with acetone, and modified by AMS. The redox states of Ero1 
mutants were assessed by non-reducing SDS-PAGE and stained with CBB. 
 
 
 
 
FIGURE 7. B 
Reduction of the Cys208-Cys241 disulfide of Ero1-AA (left) and Ero1-Cysless (right) in the 
presence of MBP-PDI (1 M) and different concentrations of GSH. All experiments were initiated by 
mixing Ero1-AA or Ero1-Cysless (4 M) with reduced MBP-PDI (1 M) in buffer containing 
NADPH (200 M), GR (1 U), and GSH (05 mM) at 30°C. The redox states of Ero1 mutants were 
detected as described in (A).  
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FIGURE 7. C 
Quantification of the “red” fraction of Ero1-AA or Ero1-Cysless in (A) and (B) (n = 3, mean ± SD). 
 
 
 
FIGURE 7. D 
Reduction of the Cys208-Cys241 disulfide of Ero1-AA (left) and Ero1-Cysless (right) in the 
presence of different concentrations of reduced PDI. All experiments were initiated by mixing Ero1-
AA or Ero1-Cysless (4 M) with reduced MBP-PDI (0-30 M) in buffer at 30°C. The redox states of 
Ero1 mutants were detected as described in (A). 
 
 
FIGURE 7. E 
Quantification of “red” fraction of Ero1-AA or Ero1-Cysless in (D) (n = 3, mean ± SD). 
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I previously demonstrated that a non-covalent Ero1-PDI complex forms through van der 
Waals contacts between a protruding -hairpin loop in Ero1 and the substrate binding pocket 
in the PDI b’ domain, and via a sustained thiol-disulfide exchange between the loop I cysteines 
of Ero1 and the a’ domain active site of PDI during catalysis (32). More recently, however, I 
found that a non-catalytic mixed-disulfide complex involving Ero1 Cys208 or Cys241 
(Ero1-PDIfast) is the predominant species detectable in the ER at steady state (18). However, 
whereas the Ero1-PDIfast complex appears to be kinetically stabilized in cells, this was hardly 
detectable in in vitro assays, suggesting that there might be additional players that stabilize 
the mixed-disulfide complex in cells. Similar mixed-disulfide complexes were also observed 
with ERp57 (18), which has a very similar overall domain arrangement to PDI (33). ERp46, 
another preferred substrate of Ero1, is composed of three Trx-like domains linked by 
unusually long flexible loops, where the three solvent -exposed redox active sites are separately 
located (34). These structural features of PDI and ERp46 could be advantageous for their close 
access to the regulatory cysteines of Ero1, leading to the facilitated activation of Ero1. 
 
EOM analysis suggested that loop I and loop II are highly flexible in solution (Fig. 4E), and 
this flexibility is likely key to the functional redox interplay between Ero1 and PDI. 
Accordingly, deletion of loop II compromised the efficiency of the Cys208 -Cys241 disulfide 
reduction by PDI. At this stage, the PDI b’ domain that houses the substrate binding pocket 
may perform an auxiliary role in another mode of the Ero1-PDI interaction. Specifically, 
Ero1 loop II might be recognized by the substrate binding pocket in the PDI b’ domain, 
resulting in the facilitated reduction of the Cys208-Cys241 disulfide by the PDI a’ domain. 
 
The presence of loop II was intrinsically inhibitory to the activity of Ero1. Accordingly, both 
Ero1-AA and Ero1-AASS displayed higher PDI oxidation activity than Ero1-AA in the 
absence of GSH (Fig. 5B, upper and 5C). Importantly, the effects on Ero1 activity caused by 
deletion of this loop and the substitution of Cys208 and Cys241 were neither additional nor 
synergistic to each other. In this context, a previous molecular dynamics simulation suggested 
that the removal of the Cys208-Cys241 disulfide induces a slight but significant rearrangement 
of the four helices embracing the FAD moiety, resulting in the enhanced access of O 2 to the 
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FAD isoalloxazine ring (18). Presumably, deletion of loop II perturbs the local conformation 
in the vicinity of the engineered site, and possibly the orientation of the two helices connected 
by loop II, resulting in similar effects on the structure and functionality of Ero1 as occur with 
the Cys208Ser/Cys241Ser double mutations. As demonstrated previously (18), a loop II 
deletion mutant that is directly comparable to Ero1-AA was not properly expressed in human 
cells, possibly due to compartment-specific ionic strength, redox balance, or degradation 
factors. Thus, loop II appears to be essential for the stabil ity of Ero1 in the native 
environment of the ER. 
 
The loop II deletion mutants presented fundamentally different phenotypes in the presence of 
GSH. Under reducing conditions in which Ero1 works at maximal turnover rate (23), these 
mutants exhibit a defect with regard to PDI oxidation and H2O2 production. My results indicate 
that this defect may be due to a decreased propensity for the deletion mutants to become 
reduced at the Cys208-Cys241 disulfide by PDI. This defect resembles the compromised 
activity of Ero1-AASS under reducing conditions, which cannot be activated by reduced PDI 
due to the absence of the Cys208-Cys241 pair (23). 
 
Collectively, my results showed that loop II provides a platform for functional interp lay with 
reduced PDI. Consequently, my in vitro experiments establish a novel regulation mechanism 
of human Ero1 (Fig. 8). During Ero1 activation, reduced PDI acts on the regulatory 
disulfides Cys94-Cys131 and Cys99-Cys104 that are located in loop I to generate active Ero1 
with the Cys94-Cys99 disulfide (35). The active Ero1 then undergoes further activation 
through reduction of the Cys208-Cys241 disulfide by the reduced PDI a’ domain, possibly 
leading to more efficient entry of O2 into the FAD-binding pocket. I previously reported that 
the four regulatory cysteines in loop I communicate with the Cys208 -Cys241 pair in loop II, 
either intramolecularly or intermolecularly. Furthermore, cleavage of the Cys208-Cys241 
disulfide appears to involve a thermodynamic preference for the Cys94-Cys131 disulfide over 
the Cys94-Cys99 disulfide, which stabilizes the inactive form of Ero1 (23). Thus, the Ero1 
hyperactive state with the Cys94-Cys99 disulfide and reduced Cys208 and Cys241 is 
presumably short-lived unless reduced PDI is continually provided. I propose that the Cys208-
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Cys241 pair acts as the second PDI-mediated switch that controls Ero1 activity by somehow 
communicating with the four regulatory cysteines in loop I. At this stage, the a vailability of 
reduced PDI, which is representative of the redox environment in the ER, essentially regulates 
the disulfide bond pattern in loop I, as well as the redox state of the Cys208-Cys241 disulfide 
in loop II. These findings highlight a dual regula tion mechanism of mammalian Ero1 that 
proceeds via redox interplay between PDI and both loop I and loop II of Ero1. 
 
 
 
FIGURE 8 
Newly proposed model of the dual regulation of Ero1 via redox interplay between PDI and flexible 
loops I and II of Ero1. Under conditions where reduced PDI is continually provided through reduction 
by GSH, the Cys208-Cys241 pair is reduced in a large proportion of Ero1molecules, leading to a 
further elevation of Ero1 activity. “Close” and “Open” indicate “Cys208/Cys241 disulfide bonded” 
and “Cys208/Cys241 reduced” Ero1, respectively. This model is based mainly on the results of in 
vitro experiments performed in the present study. Its applicability to Ero1 regulation in living cells 
needs to be further verified.  
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IV-5. Experimental procedures 
 
1. Recombinant protein expression and purification  
 
cDNAs encoding human Ero1 and human PDIs (PDI, ERp72, ERp57, ERp46 and P5) and 
their mutants were subcloned into the NdeI and BamHI sites of the pET15b vector (Novagen). 
Proteins were overexpressed in Escherichia coli  strain BL21 (DE3) and purified as described 
previously (18). Plasmids for overexpression of a set of Ero1 mutants with the deletion of the 
Arg216Gly239 segment were constructed using a PrimeSTAR Mutagenesis Basal Kit (Takara 
Bio). The resultant Ero1 mutants are single-polypeptide chains in which residues 215 and 
240 are covalently linked. The expression and purification of the Ero1 mutants were 
performed as described previously (21). 
 
 
2. Analysis of the redox state of PDIs and Ero1 
 
Purified PDIs were reduced with 10 mM dithiothreitol (DTT) for 10 min at 4 °C, and thereafter, 
DTT was removed by passing the sample through a PD-10 column (GE Healthcare) pre-
equilibrated with 50 mM Tris/HCl (pH 7.5) buffer containing 300 mM NaCl. The catalytic 
oxidation of PDIs by Ero1 was initiated by mixing 10 or 100 M of reduced PDIs with 4 M 
of each Ero1 derivative in air-saturated buffer containing 50 mM Tris/HCl (pH 7.5) and 300 
mM NaCl at 30°C. At selected time points, the reaction mixture was quenched with 5% 
trichloroacetic acid (TCA), washed with acetone, and  dissolved in buffer containing 100 mM 
Tris/HCl (pH 7.0), 1% SDS and 1 mM maleimide -PEG-2k or 4-acetamide-4’-
maleimidylstilbene-2,2’-disulfonic acid (AMS) for alkylating thiol of cysteine. All samples 
were separated by non-reducing SDS-PAGE followed by staining with Coomassie Brilliant 
Blue (CBB) or immunoblotting with antibody. The band intensity was measured for each redox 
state of PDIs and Ero1 using a LAS-3000 image reader (Fujifilm).  
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3. Statistical analysis  
 
The statistical significance of differences was examined by one-way analysis of variance 
(ANOVA) with Tukey honestly significant difference (HSD) post hoc testing. All statistical 
tests were performed using KaleidaGraph statistical software (Synergy Software) at a 
significance level of  = 0.05. 
 
 
4. Identification of digested peptides from reduced/oxidized Ero1 
 
CBB-stained SDS-PAGE gels were washed with 50% methanol, 10% acetic acid and 100 mM 
ammonium bicarbonate (AB), subjected to in-gel digestion with trypsin in 25 mM AB for 16 h 
at 37°C, and extracted with 33% and 70% acetonitrile containing 0.1% trifluoroacetic acid 
(TFA). The digested peptide fragments were analyzed by high -performance liquid 
chromatography (HPLC) (GL Science) equipped with a COSMOSIL 5C18-AR-II column 
(Nacalai Tesque) pre-equilibrated with 5% acetonitrile in 0.05% TFA, and eluted with a linear 
acetonitrile gradient ranging from 5% to 65% at a rate of 1%/min, with detection at an 
absorbance of 220 nm. The molecular masses of separated peptides were determined by matrix 
assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS; 
Bruker Daltonics) (36,37). Synthetic peptides were prepared by the Fmoc solid-phase method, 
modified with AMS, and analyzed by HPLC and MALDI-TOF MS as described previously 
(5,34,37). 
 
 
5. Differential scanning calorimetry (DSC)  
 
DSC measurements in 20 mM phosphate buffer (pH 7.0) were performed for Ero1-AA and 
Ero1-AASS using a MicroCal VP-capillary DSC (Malvern Instruments) at a scan rate of 
60°C/h, 120°C/h and 200°C/h (38). Results were cubic baseline adjusted, analyzed by 
integration of the total area under the curve, and fitted to a non -2-state model using ORIGIN 
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DSC analysis software (Origin Lab).  
 
 
6. Small-angle X-ray scattering (SAXS)  
 
SAXS measurements were performed for Ero1-AA, Ero1-AASS, and bovine serum albumin 
(BSA) (Sigma-Aldrich) as a reference for determination of the molecular mass (39) in 20 mM 
phosphate buffer (pH 7.0) containing 150 mM NaCl and 5% glycerol at the RIKEN SPring -8 
beamline BL45XU (Hyogo, Japan) (40). For each sample, 20 SAXS images were collected 
using a PILATUS 3X 2M detector (DECTRIS) at an X-ray wavelength of 1.0 Å with a camera 
distance of 2.0 m and an exposure time of 1 sec at 20.2°C. Analysis of SAXS data was carried 
out as described previously (34,38). 
 
 
7. NADPH consumption assay  
 
Measurement of NADPH consumption coupled with Ero1-catalyzed PDI oxidation was 
carried out at 30°C using a U-3310 spectrophotometer (Hitachi High-Technologies). Each 
sample solution contained 4 M Ero1 mutant, 10 M PDI, 1 mM GSH, 1 U glutathione 
reductase (GR) and 200 M NADPH (5). 
 
 
8. Measurement of O2 and H2O2 levels during Ero1-catalyzed PDI oxidation  
 
Measurement of O2 consumption were performed with a FireStingO 2 fiber-optic oxygen meter 
(Pyro Science) by mixing 100 M reduced PDI with 4 M of Ero1 mutants in O2-saturated 
buffer, or by mixing 10 M of reduced PDI with 4 M of Ero1 in the presence of 1 mM GSH, 
1 U GR and 200 M NADPH at 30°C. The level of Ero1-generated H2O2 was measured using 
a Pierce quantitative peroxide assay kit (Thermo Scientific) and Multiskan FC microplate 
reader (Thermo Scientific) as described previously (18).
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V-1. General conclusion 
 
I revealed a novel regulatory mechanism of human Ero1 through the redox-state change of 
the Cys208-Cys241 pair highly conserved in vertebrate Ero1 family enzymes. In the 
mammalian ER, more than 20 members of the PDI family and several PDI-oxidizing enzymes 
including Ero1, Prx4 and GPx7/8 have been identified (1-7). Our group demonstrated that 
Prx4 preferentially oxidizes two PDI family members, P5 and ERp46 (3). Compared to Ero1 
and Prx4, GPx7/8 has much broader specificity toward the PDI family (7). Thus, the presence 
of multiple oxidative pathways composed of the PDI family members and their upstream 
oxidases suggests a high complexity of the disulfide bond formation network in the mammalian 
ER. PDI-oxidizing enzymes are divided into two groups based on the source of oxidative pow er 
(Fig. 1). One is Ero1 which reduces O2 to H2O2, and the other is the peroxidase family such 
as Prx4 and GPx7/8, which reduce H2O2 to H2O. Thus, the catalysis of oxidative protein folding 
in the mammalian ER utilizes both O2 and H2O2. It was recently reported that GPx7/8 interact 
with Ero1 and utilize Ero1-generated H2O2 (8-10). These observations imply that Ero1 is 
the most upstream enzyme on the disulfide bond formation pathways in the mammalian ER. 
 
My previous experiment demonstrated that Ero1-AASS without the Cys208-Cys241 disulfide 
yielded still larger amount of H2O2 than hyperactive Ero1, resulting in severe defect in cell 
proliferation and viability (10). These results indicate that the Cys208-Cys241 pair of Ero1 
controls not only H2O2 generation in the ER but also some essential cellular functions. H2O2 
is an intracellular metabolite that serves as the second messenger in redox signaling (11). 
Nevertheless, excess amount of H2O2 damages proteins, nucleic acids, and lipids through 
peroxidation reaction (12). Therefore, temporal and spatial limitation of the H2O2 level is 
critical for the cellular quality control . In this respect, the present work that revealed a novel 
mechanism of Ero1 regulation is of cell biological significance.  
 
Since the disulfide bond formation network in the mammalian ER is required for the 
biosynthesis of secretary and membrane proteins such as insulin, immunoglobulin, hormone 
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and so on and play essential roles in protein quality control,  the disruption of this network 
causes several serious diseases including Type II diabetes and neurodegenerative 
proteinopathies. I expect that further advances in my research will shed more light on 
molecular level understanding of  the pathogenic mechanisms of various diseases caused by 
structural and functional protein aberrations in cells. 
 
 
 
FIGURE 1 
Disulfide bond formation network in the mammalian ER.  
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